Embecta Corp.
A maker of insulin pen needles, syringes, and safety injection devices for people living with diabetes, serving them in more than 100 countries. Its roots trace to 1924, when Becton, Dickinson made the world's first specialized insulin syringe; the business was spun off as its own company in 2022. The name blends "em" for empathy with "bect" from Becton, Dickinson, keeping its century-old heritage while striking out on its own.
Granted 757.9K
Granted 118.7K
Granted 96.5K
Granted 91.7K
Granted 77.3K
Granted 32.3K · Bought 31.2K
Granted 78.6K
Granted 48.1K
Granted 48.1K
Granted 48.1K
Granted 48.1K
Granted 48.1K
Granted 48.1K · Sold 3.1K
Granted 25.3K
Granted 13.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Kurdikar DevdattPresident and CEO, Director · 10 transactions | +216.6% | 774.9K | 757.9K | — | — |
| Elguicze JacobSVP and CFO · 6 transactions | +337.9% | 289.1K | 118.7K | — | — |
| Mann Jeffrey ZSVP, GC, Head Corp. Dev., Secy · 5 transactions | +339% | 242.9K | 96.5K | — | — |
| Curtis ShaunSVP, Global Manuf./Sup. Chain · 8 transactions | +265.2% | 95.3K | 91.7K | — | — |
| Casner JeanChief Human Resources Officer · 7 transactions | +680.6% | 88.0K | 77.3K | — | — |
| Melcher David FDirector · 7 transactions | +303.8% | 86.7Kas of May 2025 | 32.3K | 31.2K | — |
| Roth Anthony M.VP, Chief Accounting Officer · 4 transactions | — | 78.8K | 78.6K | — | — |
| Reidy Christopher RDirector · 3 transactions | +241.1% | 70.1K | 48.1K | — | — |
| Pomeroy ClaireDirector · 3 transactions | +351.9% | 66.1K | 48.1K | — | — |
| Hombach Robert J.Director · 3 transactions | +394% | 64.6K | 48.1K | — | — |
| Anderson Carrie LDirector · 3 transactions | +394.2% | 64.6K | 48.1K | — | — |
| Prange KarenDirector · 3 transactions | +394.2% | 64.6K | 48.1K | — | — |
| Morris Milton MayoDirector · 4 transactions | +360% | 60.1K | 48.1K | — | 3.1K |
| Albritton DavidDirector · 2 transactions | +204.1% | 39.7Kas of Feb 2025 | 25.3K | — | — |
| Capone BrianVP, CAO & Corp. Controller · 2 transactions | +143.7% | 21.1Kas of Nov 2023 | 13.7K | — | — |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last 3 years: +28.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.